Trial intelligence / Profile preview

Apratastat in Active Rheumatoid Arthritis

NCT00095342Phase 2Completed

Sponsor
Pfizer
Primary completion
Aug 2005
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of apratastat in rheumatoid arthritis (RA), sponsored by Pfizer. Status: completed.

02

Drugs

apratastat
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00095342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00095342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call